Biohaven Pharmaceutical Holding Stock Market Value
| BHVN Stock | USD 46.38 0.90 1.90% |
| Symbol | Biohaven |
Biohaven Pharmaceutical Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.37) | Return On Assets (1.19) | Return On Equity (2.65) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biohaven Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biohaven Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biohaven Pharmaceutical.
| 06/01/2024 |
| 11/28/2024 |
If you would invest 0.00 in Biohaven Pharmaceutical on June 1, 2024 and sell it all today you would earn a total of 0.00 from holding Biohaven Pharmaceutical Holding or generate 0.0% return on investment in Biohaven Pharmaceutical over 180 days. Biohaven Pharmaceutical is related to or competes with Immunome, Inhibrx, Day One, Terns Pharmaceuticals, X4 Pharmaceuticals, Inozyme Pharma, and Mereo BioPharma. Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients ... More
Biohaven Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biohaven Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biohaven Pharmaceutical Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.56 | |||
| Information Ratio | 0.0307 | |||
| Maximum Drawdown | 22.52 | |||
| Value At Risk | (3.90) | |||
| Potential Upside | 6.52 |
Biohaven Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biohaven Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biohaven Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Biohaven Pharmaceutical historical prices to predict the future Biohaven Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0586 | |||
| Jensen Alpha | 0.1163 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0421 | |||
| Treynor Ratio | 0.241 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biohaven Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biohaven Pharmaceutical Backtested Returns
Biohaven Pharmaceutical appears to be very steady, given 3 months investment horizon. Biohaven Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.089, which signifies that the company had a 0.089% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Biohaven Pharmaceutical Holding, which you can use to evaluate the volatility of the firm. Please makes use of Biohaven Pharmaceutical's Mean Deviation of 2.47, downside deviation of 2.56, and Risk Adjusted Performance of 0.0586 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Biohaven Pharmaceutical holds a performance score of 7. The firm shows a Beta (market volatility) of 0.93, which signifies possible diversification benefits within a given portfolio. Biohaven Pharmaceutical returns are very sensitive to returns on the market. As the market goes up or down, Biohaven Pharmaceutical is expected to follow. Please check Biohaven Pharmaceutical's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Biohaven Pharmaceutical's price patterns will revert.
Auto-correlation | 0.49 |
Average predictability
Biohaven Pharmaceutical Holding has average predictability. Overlapping area represents the amount of predictability between Biohaven Pharmaceutical time series from 1st of June 2024 to 30th of August 2024 and 30th of August 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biohaven Pharmaceutical price movement. The serial correlation of 0.49 indicates that about 49.0% of current Biohaven Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 32.42 |
Biohaven Pharmaceutical lagged returns against current returns
Autocorrelation, which is Biohaven Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biohaven Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Biohaven Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Biohaven Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biohaven Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biohaven Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biohaven Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biohaven Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Biohaven Pharmaceutical Lagged Returns
When evaluating Biohaven Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biohaven Pharmaceutical stock have on its future price. Biohaven Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biohaven Pharmaceutical autocorrelation shows the relationship between Biohaven Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Biohaven Pharmaceutical Holding.
Regressed Prices |
| Timeline |
Pair Trading with Biohaven Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biohaven Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Biohaven Stock
Moving against Biohaven Stock
| 0.86 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.69 | RGNX | Regenxbio | PairCorr |
| 0.67 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.65 | INKT | Mink Therapeutics | PairCorr |
| 0.56 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Biohaven Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biohaven Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biohaven Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biohaven Pharmaceutical Holding to buy it.
The correlation of Biohaven Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biohaven Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biohaven Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biohaven Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Biohaven Pharmaceutical Correlation, Biohaven Pharmaceutical Volatility and Biohaven Pharmaceutical Alpha and Beta module to complement your research on Biohaven Pharmaceutical. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.